Skip to main content
. 2019 Feb;36(Suppl 1):S22–S26.

TABLE 1.

Baseline Patient Characteristics

Variables Zoledronic Acid Interval Dosing

Standard (n = 121) Extended (n = 35)
Age, mean (SD), y 69 (10) 68 (10)

Race, No. (%)
 White 45 (37) 10 (29)
 African American 75 (62) 25 (71)
 Other 1 (1) 0 (0)

Sex, No. (%)
 Male 118 (98) 34 (97)
 Female 3 (2) 1 (3)

Malignancy, No. (%)
 Multiple myeloma 21 (7) 7 (20)
 Prostate cancer 100 (83) 28 (80)

Dental screening, No. (%)
 Before 17 (14) 6 (17)
 During 21 (17) 7 (20)